Caprock Group, Inc. Repligen Corp Transaction History

Caprock Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$161.19 - $257.96 $180,532 - $288,915	-1,120 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$247.59 - $304.47 $40,604 - $49,933	-164 Reduced 12.77%	1,120 $297,000
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $165 - $220	1 Added 0.08%	1,284 $256,000
Q1 2021 Apr 29, 2021	SELL	$180.37 - $226.26 $4,148 - $5,203	-23 Reduced 1.76%	1,283 $249,000
Q4 2020 Jan 29, 2021	SELL	$148.08 - $206.57 $159,630 - $222,682	-1,078 Reduced 45.22%	1,306 $250,000
Q3 2020 Oct 29, 2020	BUY	$122.51 - $158.27 $9,800 - $12,661	80 Added 3.47%	2,384 $352,000
Q2 2020 Aug 05, 2020	SELL	$94.33 - $140.48 $122,534 - $182,483	-1,299 Reduced 36.05%	2,304 $285,000
Q1 2020 Apr 28, 2020	BUY	$84.96 - $109.14 $63,125 - $81,091	743 Added 25.98%	3,603 $348,000
Q4 2019 Feb 04, 2020	SELL	$73.84 - $93.08 $3,322 - $4,188	-45 Reduced 1.55%	2,860 $265,000
Q3 2019 Oct 31, 2019	SELL	$76.65 - $95.51 $39,704 - $49,474	-518 Reduced 15.13%	2,905 $223,000
Q1 2019 Apr 12, 2019	BUY	$49.45 - $62.8 $169,267 - $214,964	3,423 New	3,423 $202,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.